SCCRO promotes glioma formation and malignant progression in mice

Neoplasia

Volumn 12, Issue 6, 2010, Pages 476-484

  Broderick, Stephen R ^a   Golas, Benjamin J ^a   Pham, Duykhanh ^a   Towe, Christopher W ^a   Talbot, Simon G ^a   Kaufman, Andrew ^a   Bains, Sarina ^a   Huryn, Laryssa A ^a   Yonekawa, Yoshihiro ^a   Carlson, Diane ^a   Hambardzumyan, Dolores ^a   Ramanathan, Yegnanarayana ^a   Singh, Bhuvanesh ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; NESTIN; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA; SQUAMOUS CELL CARCINOMA RELATED ONCOPROTEIN; UNCLASSIFIED DRUG; DCUN1D1 PROTEIN, HUMAN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; PTEN PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER STEM CELL; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; EMBRYO; GENE ACTIVITY; GENE DELETION; GENE FUNCTION; GENE LOSS; GENE OVEREXPRESSION; GENE REPLICATION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; WILD TYPE; ANIMAL; BRAIN NEOPLASMS; C57BL MOUSE; CELL DIFFERENTIATION; EMBRYONIC STEM CELL; ENZYME IMMUNOASSAY; FEMALE; GENETICS; KNOCKOUT MOUSE; LETHAL GENE; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL DIFFERENTIATION; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EMBRYONIC STEM CELLS; FEMALE; GENES, LETHAL; GLIOMA; HUMANS; IMMUNOENZYME TECHNIQUES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-SIS; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77953219714     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.10202     Document Type: Article

References (49)

1. Balsara BR, Sonoda G, du Manoir S, Siegfried JM, Gabrielson E, and Testa JR (1997). Comparative genomic hybridization analysis detects frequent, often high-level, overrepresentation of DNA sequences at 3q, 5p, 7p, and 8q in human non-small cell lung carcinomas. Cancer Res 57, 2116-2120.
2. Bjorkqvist AM, Husgafvel-Pursiainen K, Anttila S, Karjalainen A, Tammilehto L, Mattson K, Vainio H, and Knuutila S (1998). DNA gainsin3qoccurfrequentlyin squamous cell carcinoma of the lung, but not in adenocarcinoma. Genes Chromo-somes Cancer 22, 79-82.
3. Bockmuhl U, Schluns K, Kuchler I, Petersen S, and Petersen I (2000). Genetic imbalances with impact on survival in head and neck cancer patients. Am J Pathol 157, 369-375.
4. Brieger J, Jacob R, Riazimand HS, Essig E, Heinrich UR, Bittinger F, and Mann WJ (2003). Chromosomal aberrations in premalignant and malignant squamous epithelium. Cancer Genet Cytogenet 144, 148-155.
5. Hashimoto Y, Oga A, Kawauchi S, Furuya T, Shimizu N, Nakano T, Imate Y, Yamashita H, and Sasaki K (2001). Amplification of 3q26 approximately qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 129, 52-56.
6. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, Auer G, and Ried T (1997). Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosomes Cancer 19, 233-240.
7. Heselmeyer K, Schrock E, du Manoir S, Blegen H, Shah K, Steinbeck R, Auer G, and Ried T (1996). Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93, 479-484.
8. Kettunen E, el-Rifai W, Bjorkqvist AM, Wolff H, Karjalainen A, Anttila S, Mattson K, Husgafvel-Pursiainen K, and Knuutila S (2000). A broad amplifi-cation pattern at 3q in squamous cell lung cancer-a fluorescence in situ hybridization study. Cancer Genet Cytogenet 117, 66-70.
9. Mayama T, Fukushige S, Shineha R, Nishihira T, Satomi S, and Horii A (2000). Frequent loss of copy number on the long arm of chromosome 21 in human esophageal squamous cell carcinoma. Int J Oncol 17, 245-252.
10. Riazimand SH, Welkoborsky HJ, Bernauer HS, Jacob R, and Mann WJ (2002). Investigations for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck. Oncology 63,385-392.
11. Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, Murakami Y, Nakamura Y, and Inazawa J (1999). Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon. Genes Chromosomes Cancer 24, 337-344.
12. Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A, and Rao PH (2001). Molecular cytogenetic characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61, 4506-4513.
13. Singh B, Reddy PG, Goberdhan A, Walsh C, Dao S, Ngai I, Chou TC, O-charoenrat P, Levine AJ, Rao PH, et al. (2002). p53 regulates cell survival by inhibiting PIK3CA in squamous cell carcinomas. Genes Dev 16, 984-993.
14. Singh B, Stoffel A, Gogineni S, Poluri A, Pfister DG, Shaha AR, Pathak A, Bosl G, Cordon-Cardo C, Shah JP, et al. (2002). Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas. Am J Pathol 161, 365-371.
15. Singh B, Wreesmann VB, Pfister D, Poluri A, Shaha AR, Kraus D, Shah JP, and Rao PH (2002). Chromosomal aberrations in patients with head and neck squamous cell carcinoma do not vary based on severity of tobacco/alcohol exposure. BMC Genet 3, 22.
16. Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, Drabkin HA, and Gemmill RM (2000). Molecular definition of a small amplification domain within 3q26 in tumorsofcervix, ovary, and lung. Cancer Genet Cytogenet 117, 9-18.
17. Wreesmann VB and Singh B (2005). Chromosomal aberrations in squamous cell carcinomas of the upper aerodigestive tract: biologic insights and clinical opportunities. J Oral Pathol Med 34, 449-459.
18. Guan XY, Sham JS, Tang TC, Fang Y, Huo KK, and Yang JM (2001). Isolation of a novel candidate oncogene within a frequently amplified region at 3q26 in ovarian cancer. Cancer Res 61, 3806-3809.
19. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, Ratovitski EA, Jen J, and Sidransky D (2000). AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97, 5462-5467.
20. Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, and Gray JW (1999). PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21, 99-102.
21. Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, et al. (2006). Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res 66, 9437-9444.
22. Estilo CL, O-charoenrat P, Ngai I, Patel SG, Reddy PG, Dao S, Shaha AR, Kraus DH, Boyle JO, Wong RJ, et al. (2003). The role of novel oncogenes squamous cell carcinoma-related oncogene and phosphatidylinositol 3-kinase p110α in squamous cell carcinoma of the oral tongue. Clin Cancer Res 9, 2300-2306.
23. O-charoenrat P, Sarkaria I, Talbot SG, Reddy P, Dao S, Ngai I, Shaha A, Kraus D, Shah J, Rusch V, et al. (2008). SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2. Clin Cancer Res 14, 6780-6789.
24. Talbot SG, O-charoenrat P, Sarkaria IS, Ghossein R, Reddy P, Ngai I, Cordeiro CN, Wong RJ, Kris MG, Rusch VW, et al. (2004). Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A. Ann Surg Oncol 11, 530-534.
25. Guardavaccaro D and Pagano M (2004). Oncogenic aberrations of cullindependent ubiquitin ligases. Oncogene 23, 2037-2049.
26. Sufan RI and Ohh M (2006). Role of the NEDD8 modification of Cul2 in the sequential activation of ECV complex. Neoplasia 8, 956-963.
27. Orsulic S (2002). An RCAS-TVA-based approach to designer mouse models. Mamm Genome 13, 543-547.
28. Witte HT, Jeibmann A, Klambt C, and Paulus W (2009). Modeling glioma growth and invasion in Drosophila melanogaster. Neoplasia 11, 882-888.
29. Dai C, Celestino JC, Okada Y, Louis DN, Fuller GN, and Holland EC (2001). PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15, 1913-1925.
30. Morrison TB, Weis JJ, and Wittwer CT (1998). Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Bio-techniques 24, 954-958, 960, 962.
31. Kim AY, Bommelje CC, Lee BE, Yonekawa Y, Choi L, Morris LG, Huang G, Kaufman A, Ryan RJ, Hao B, et al. (2008). SCCRO (DCUN1D1) is an essential component of the E3 complex for neddylation. J Biol Chem 283, 33211-33220.
32. Holland EC (2000). A mouse model for glioma: biology, pathology, and therapeutic opportunities. Toxicol Pathol 28, 171-177.
33. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, and Kleihues P (2007). The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114, 97-109.
34. Hui AB, Lo KW, Yin XL, Poon WS, and Ng HK (2001). Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. Lab Invest 81, 717-723.
35. Lee SH, Lumelsky N, Studer L, Auerbach JM, and McKay RD (2000). Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol 18, 675-679.
36. Perrier AL, Tabar V, Barberi T, Rubio ME, Bruses J, Topf N, Harrison NL, and Studer L (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 101, 12543-12548.
37. Doetsch F (2003). The glial identity of neural stem cells. Nat Neurosci 6, 1127-1134.
38. Kurz T, Chou YC, Willems AR, Meyer-Schaller N, Hecht ML, Tyers M, Peter M, and Sicheri F (2008). Dcn1 functions as a scaffold-type E3 ligase for cullin neddylation. Mol Cell 29, 23-35.
39. Kurz T, Ozlu N, Rudolf F, O'Rourke SM, Luke B, Hofmann K, Hyman AA, Bowerman B, and Peter M (2005). The conserved protein DCN-1/Dcn1p is required for cullin neddylation in C. elegans and S. cerevisiae. Nature 435, 1257-1261.
40. Shih AH and Holland EC (2006). Platelet-derived growth factor (PDGF) and glial tumorigenesis. Cancer Lett 232, 139-147.
41. Shih AH, Dai C, Hu X, Rosenblum MK, Koutcher JA, and Holland EC (2004). Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64, 4783-4789.
42. Liu Y, Yeh N, Zhu XH, Leversha M, Cordon-Cardo C, Ghossein R, Singh B, Holland E, and Koff A (2007). Somatic cell type specific gene transfer reveals a tumor-promoting function for p21(Waf1/Cip1). EMBO J 26, 4683-4693.
43. Ruano Y, Mollejo M, Ribalta T, Fiano C, Camacho FI, Gomez E, de Lope AR, Hernandez-Moneo JL, Martinez P, and Melendez B (2006). Identification of novel candidate target genes in amplicons of glioblastoma multiforme tumors detected by expression and CGH microarray profiling. Mol Cancer 5, 39.
44. Le Mercier M, Fortin S, Mathieu V, Roland I, Spiegl-Kreinecker S, Haibe-Kains B, Bontempi G, Decaestecker C, Berger W, Lefranc F, et al. (2009). Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia 11, 485-496.
45. Duerr EM, Rollbrocker B, Hayashi Y, Peters N, Meyer-Puttlitz B, Louis DN, Schramm J, Wiestler OD, Parsons R, Eng C, et al. (1998). PTEN mutations in gliomas and glioneuronal tumors. Oncogene 16, 2259-2264.
46. Zhu H, Acquaviva J, Ramachandran P, Boskovitz A, Woolfenden S, Pfannl R, Bronson RT, Chen JW, Weissleder R, Housman DE, et al. (2009). Oncogenic EGFR signaling cooperates with loss of tumor suppressor gene functions in glio-magenesis. Proc Natl Acad Sci USA 106, 2712-2716.
47. Hershko A and Ciechanover A (1998). The ubiquitin system. Annu Rev Biochem 67,425-479.
48. Mukhopadhyay D and Riezman H (2007). Proteasome-independent functions of ubiquitin in endocytosis and signaling. Science 315, 201-205.
49. Ciechanover A, DiGiuseppe JA, Bercovich B, Orian A, Richter JD, Schwartz AL, and Brodeur GM (1991). Degradation of nuclear oncoproteins by the ubiquitin system in vitro. Proc Natl Acad Sci USA 88, 139-143.